Artemis Investment Management LLP Iovance Biotherapeutics, Inc. Transaction History

Artemis Investment Management LLP

  • $6.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$16.55 - $27.63 $974,679 - $1.63 Million
-58,893 Closed
0 $0
Q3 2021

Oct 26, 2021
SELL
$20.35 - $26.63 $11,579 - $15,152
-569 Reduced 0.96%
58,893 $1.45 Million
Q2 2021

Aug 04, 2021
BUY
$16.33 - $33.07 $971,014 - $1.97 Million
59,462 New
59,462 $1.55 Million

Others Institutions Holding IOVA

# of Institutions
314
Shares Held
241M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email